openPR Logo
Press release

Point of Care (POC) Molecular Diagnostics Market Worth $2.32 billion by 2027

03-17-2020 07:54 AM CET | Health & Medicine

Press release from: Meticulous Research

Point of Care Molecular Diagnostics

Point of Care Molecular Diagnostics

According to a new market research report "Point of Care Molecular Diagnostics Market by Product & Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application (Respiratory Diseases, Hospital Acquired Infections, STD), and End User - Global Forecast to 2027", published by Meticulous Research, the point of care (POC) molecular diagnostics market is expected to grow at a CAGR of 13% from 2019 to reach $2.32 billion by 2027.

Most of the diagnostic tests are carried out in central laboratories equipped with sophisticated bench-top instruments for various diseases like respiratory, sexually transmitted, cancer, hospital-acquired infections, and others. However, for getting results, patients have to stay for longer time in some instances. This leads to a delay in diagnosis and further treatment; thereby increases the mortality rate. To overcome these drawbacks, decentralized or point of care testing has been emerged.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5081

Transition of molecular diagnostics from centralized labs to decentralized settings put major challenges in front of vendors, as molecular diagnosis is highly related to genes, molecular markers, and DNA/RNA expressions. Using various technologies like RT-qPCR, isothermal amplification technology among others, vendors developed molecular diagnostics tests at point of care settings. This helps physicians to further improve the standard of care by combining the ability to quickly make a diagnosis and treatment decision during the patient's initial visit rather than having to wait for hours.

The POC molecular diagnostics market study presents historical market data in terms of value (2017, and 2018), estimated current data (2019), and forecasts for 2027 - by product & solution, technology, application, and end-user. The study also evaluates industry competitors and analyzes the market at the regional and country level.

On the basis of technology, the RT-qPCR segment held the largest share of the POC molecular diagnostics market in 2019. The largest share of this segment is mainly attributed to its features of identifying amplified fragments in real-time and in more specific, sensitive, and reproducible way compared to traditional PCR. Moreover, large number of commercially available RT-qPCR based POC molecular diagnostic systems or tests, growing need for rapid diagnosis of viral & infectious diseases, and increasing utilization of RT-qPCR in proteomics & genomics are some of the other factors expected to drive the growth of this technology.

Make an enquiry of this Report https://www.meticulousresearch.com/enquire-before-buying/cp_id=5081

On the basis of product and solution, kits & assays expected to grow at the highest CAGR during the forecast period owing to their frequent and repetitive usage, growing focus on commercializing disease-specific assays for early diagnosis, technological advancements, and focus on receiving CLIA approvals for disease-specific POC molecular diagnostic products.

On the basis of application, respiratory diseases commanded the largest share of the overall POC molecular diagnostics market in 2019, attributed to the fact that number of respiratory infectious diseases associated with aging population and environmental factors is growing continuously. This leads to the increase in the number of commercialized infectious disease specific POC molecular diagnostic products in the market.

Based on the end user, clinics and diagnostic laboratories commanded the largest share of the overall POC molecular diagnostics market in 2019, followed by hospital outpatient departments and intensive care units (ICUs), research and academic institutes, and other end users. The factors such as increasing focus of key companies on offering disease specific POC molecular diagnostics to cater larger customer base, growing demand for POC technologies to be used within the physician's offices or associated diagnostic labs, and growing awareness regarding early diagnosis contributed to the largest share of the clinics and diagnostic laboratories in this market.

Geographically, North America dominated the overall POC molecular diagnostics market in 2019, followed by Europe and Asia Pacific. The factors such as growing awareness about the early diagnosis of chronic diseases, rising number of cases with infectious diseases, increasing venture capital funding, development and commercialization of CLIA-waived tests/systems, and strong presence of key players in this region supported the largest share of North America in the POC molecular diagnostics market. However, POC molecular diagnostics market in Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. The key factors driving the growth of this market are rising incidences of chronic diseases associated with geriatric population, expansion of key market players in this region, insufficient sophisticated central laboratory testing services, and potential cost effectiveness of POC molecular diagnosis.

You Can Directly Buy This Report From Here:: https://www.meticulousresearch.com/buy_now.php?pformat=382&vformat=1132
(Get key industry insights spread across 248 pages with 211 market data tables & 47 figures & charts from the report)

The report also includes extensive assessment of the product portfolio, geographic analysis, and key strategic developments adopted by the leading market participants in the industry over the past 4 years (2016-2019). The POC molecular diagnostics market has witnessed number of new product launches; approvals; agreements, partnerships, and collaborations; and expansions and acquisitions in the recent years. For instance, in October 2019, Cepheid (U.S.) received clearance from the U.S. Food and Drug Administration for Xpert BCR-ABL Ultra. This helped monitoring of BCR-ABL levels in patients with Chronic Myeloid Leukemia (CML) under 3 hours. In July 2017, F. Hoffmann-La Roche Ltd (Switzerland) launched cobas MRSA/SA nucleic acid assay for the qualitative detection and differentiation of methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus (SA) at the point of care on cobas Liat PCR System.

The key players operating in the global POC molecular diagnostics market are Alere Inc. (U.S.), DxNA, LLC. (U.S.), Mesa Biotech Inc. (U.S.), Meridian Bioscience Inc. (U.S.), Danaher Corporation (U.S.), Quidel Corporation (U.S.), Biocartis Group NV (Belgium), bioMérieux SA (France), Thermo Fisher Scientific (U.S.), and F. Hoffmann-La Roche Ltd. (Switzerland), among others.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/point-of-care-molecular-diagnostics-market-5081/

Scope of the Report:

POC Molecular Diagnostics Market by Technology

Real-Time Polymerase Chain Reaction (RT-qPCR),
Isothermal Nucleic Acid Amplification Technology (INAAT)
Other Technologies
POC Molecular Diagnostics Market by Product & Solution

Kits & Assays
Analyzers
Software & Services
POC Molecular Diagnostics Market by Application

Respiratory Diseases
Sexually Transmitted Diseases
Cancer/Oncology
Hospital Acquired Infections
Neonatal/Prenatal Testing
Other Applications
POC Molecular Diagnostics Market by End User

Clinics and Diagnostic Laboratories
Hospital Outpatient Departments and Intensive Care Units (ICUs)
Research and Academic Institutes
Other End Users
POC Molecular Diagnostics Market by Geography

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5081

Key questions answered in the report-

Which are the high growth market segments in terms of product & solution, technology, application, end-users, and region/countries?
What was the historical market for point of care molecular diagnostics across the globe?
What are the market forecasts and estimates for the period 2019-2027?
What are the major drivers, restraints, opportunities, and challenges in the global point of care molecular diagnostics market?
Who are the major players in the point of care molecular diagnostics market?
How is the competitive landscape and who are the market leaders in the global point of care molecular diagnostics market?
What are the recent developments in the global point of care molecular diagnostics market?
What are the different strategies adopted by the major players in the global point of care molecular diagnostics market?
What are the geographic trends and high growth regions/ countries?

Related Reports:
Point of Care Diagnostics Market by Test (Glucose, Cardiac, HbA1c, HIV, STD, HCV, Pregnancy, Cancer, Hematology), Platform (Immunoassay, Microfluidics, MDx), Mode (Prescription, OTC), End-User (Hospital, At Home, OPD) - Global Forecast To 2024
https://www.meticulousresearch.com/product/point-of-care-diagnostics-poc-market/

Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology and Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End-User (Hospital, CRO) - Global Forecast to 2024
https://www.meticulousresearch.com/product/tissue-diagnostics-market-4971/

Contact Us:
Meticulous Research
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

About Meticulous Research
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present critical market data with great attention to details.
Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Point of Care (POC) Molecular Diagnostics Market Worth $2.32 billion by 2027 here

News-ID: 1970263 • Views: …

More Releases from Meticulous Research

The Cloud Managed Services Market is projected to reach $247.5 billion by 2030
The Cloud Managed Services Market is projected to reach $247.5 billion by 2030, growing at a robust CAGR of 14.2% from 2023 to 2030. This growth is fueled by advancements in cloud technologies, increasing demand in sectors like BFSI and healthcare, and a rising focus on customized and managed cloud services. However, challenges such as high costs, security risks, compliance issues, and limited flexibility may impact market growth. Download free…
Language Learning Market Projected to Reach $124.6 Billion by 2031
Meticulous Research® recently published a report titled, "Language Learning Market by Age Group (40 years), Language (English, Mandarin, Spanish, French, German, Italian, Japanese), End User (B2C, B2B), and Geography - Global Forecast to 2031." Download sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5561 According to the report, the language learning market is anticipated to reach $124.6 billion by 2031, growing at a CAGR of 10.7% from 2024 to 2031. Key factors fueling this growth…
Oncology Information Systems Market to be Worth $4.45 Billion by 2030: Analytica …
Introduction: Meticulous Research® recently released a comprehensive report titled "Oncology Information Systems Market By Offering (Software, Services) Application (Medical, Surgical, Radiology Oncology) End User (Hospital, Diagnostic Imaging Center, Cancer Care Center) - Global Forecast to 2030." The report reveals that the oncology information systems (OIS) market is projected to reach approximately $4.45 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.4% from 2024. This growth is…
IoT Sensors Market to be Worth $56.8 Billion by 2030
IoT Sensors Market to be Worth $56.8 Billion by 2030
Meticulous Research®-a leading global market research company, published a research report titled, 'IoT Sensors Market by Offering (Image Sensors, RFID Sensors, Biosensors, Humidity Sensors, Optical Sensors, Others), Technology (Wired, Wireless), Sector (Manufacturing, Retail, Consumer Electronics, Others), & Geography - Global Forecast to 2030.' According to this latest publication from Meticulous Research®, in terms of value, the IoT sensors market is projected to reach $56.8 billion by 2030, at a CAGR of…

All 5 Releases


More Releases for POC

Primary Catalyst Driving POC Medical Imaging Market Evolution in 2025: Chronic D …
What market dynamics are playing a key role in accelerating the growth of the poc medical imaging market? The escalating occurrence of long-term diseases is predicted to boost the expansion of the point-of-care medical imaging market in the future. The chronic disease prevalence pertains to the fraction or the count of people in a community affected by enduring health ailments at any given moment. This transition originates from lifestyle options, inherited…
Transforming the Point-of-Care (POC) Coagulation Testing Market in 2025: Cardiov …
"What Is the Expected Size and Growth Rate of the Point-of-Care (POC) Coagulation Testing Market? The point-of-care (POC) coagulation testing market has grown significantly in recent years. It will grow from $1.18 billion in 2024 to $1.25 billion in 2025, at a CAGR of 5.8%. The growth is driven by increasing patient demand, the growing trend of point-of-care testing, high reliability in coagulation status testing, automation, integration with electronic health records…
POC Diagnostic Testing Devices | 1drop
1drop Inc.'s POC diagnostic testing devices are essential tools in modern healthcare, designed to deliver quick and accurate results for various health conditions at the point of care. These devices make diagnostics more accessible and timelier, enhancing healthcare delivery and patient outcomes. Point-of-Care Molecular Diagnostic Platform 1drop offers a comprehensive POC molecular diagnostic platform that consists of three main components: • Reagent: Specialized reagents formulated for specific tests, including molecular diagnostics. • Device: The 1POT™ Duo…
POC Diagnostics Market Size 2024 to 2031.
Market Overview and Report Coverage POC, or Point of Care, Diagnostics refer to medical tests that are performed outside of a traditional laboratory setting, allowing for quicker results and immediate treatment decisions. The POC Diagnostics Market encompasses a wide range of diagnostic tests including blood glucose monitoring, pregnancy tests, infectious disease testing, and more. The future outlook of the POC Diagnostics Market is optimistic, with the market expected to grow…
Point of Care (POC) Coagulation Testing Devices Market - Transforming Coagulatio …
Newark, New Castle, USA: The "Point of Care (POC) Coagulation Testing Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Point of Care (POC) Coagulation Testing Devices…
POC Cardiovascular Diagnostic Market 2022 | Detailed Report
According to Market Study Report, POC Cardiovascular Diagnostic Market provides a comprehensive analysis of the POC Cardiovascular Diagnostic Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5467652 The report provides a comprehensive analysis of company profiles listed below: - Abbott - Biomerieux - Danaher - F.…